![](/wp-content/themes/puzz_20240709/assets/lp/doc_en/img/slide001_img1.jpg)
![](/wp-content/themes/puzz_20240709/assets/lp/doc_en/img/slide001_img1sp.jpg)
Crafting the future of
clinical trials in Japan
![](/wp-content/themes/puzz_20240709/assets/lp/doc_en/img/buzzreach_logo.png)
Welcome to Buzzreach
Please Download
Capability Document
![](/wp-content/themes/puzz_20240709/assets/lp/doc_en/img/slide001_img2sp.jpg)
COMPANY
Company Buzzreach Inc.
HeadquarterKowa Shirokanedai
Building 8F.3-19-1 Shirokanedai,
Minato-ku. Tokyo 108-0071
Establishment 2017 June 23
Capital890,325,015 JPY(Including capital reserve)
CEO Takateru Inokawa
COO Kiyoshi Aoyagi
Welcome to Buzzreach
Please Download
Capability Document
![](/wp-content/themes/puzz_20240709/assets/lp/doc_en/img/slide001_img3.jpg)
COMPANY
Company Buzzreach Inc.
HeadquarterKowa Shirokanedai
Building 8F.3-19-1 Shirokanedai,
Minato-ku. Tokyo 108-0071
Establishment 2017 June 23
Capital890,325,015 JPY(Including capital reserve)
CEO Takateru Inokawa
COO Kiyoshi Aoyagi
Welcome to Buzzreach
Please Download
Capability Document
![](/wp-content/themes/puzz_20240709/assets/lp/doc_en/img/slide001_img4.jpg)
![](/wp-content/themes/puzz_20240709/assets/lp/doc_en/img/slide001_img4sp.jpg)
Welcome to Buzzreach
Please Download
Capability Document